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Indanomycin is biosynthesized by a hybrid nonribosomal peptide synthase/
polyketide synthase (NRPS/PKS) followed by a number of ‘tailoring’ steps to
form the two ring systems that are present in the mature product. It had
previously been hypothesized that the indane ring of indanomycin was formed
by the action of IdmH using a Diels–Alder reaction. Here, the crystal structure
of a selenomethionine-labelled truncated form of IdmH (IdmH-99–107) was
solved using single-wavelength anomalous dispersion (SAD) phasing. This
truncated variant allows consistent and easy crystallization, but importantly the
structure was used as a search model in molecular replacement, allowing the
full-length IdmH structure to be determined to 2.7 A˚ resolution. IdmH is a
homodimer, with the individual protomers consisting of an + barrel. Each
protomer contains a deep hydrophobic pocket which is proposed to constitute
the active site of the enzyme. To investigate the reaction catalysed by IdmH,
88% of the backbone NMR resonances were assigned, and using chemical shift
perturbation of [15N]-labelled IdmH it was demonstrated that indanomycin
binds in the active-site pocket. Finally, combined quantum mechanical/
molecular mechanical (QM/MM) modelling of the IdmH reaction shows that
the active site of the enzyme provides an appropriate environment to promote
indane-ring formation, supporting the assignment of IdmH as the key Diels–
Alderase catalysing the final step in the biosynthesis of indanomycin through a
similar mechanism to other recently characterized Diels–Alderases involved in
polyketide-tailoring reactions. An animated Interactive 3D Complement
(I3DC) is available in Proteopedia at https://proteopedia.org/w/Journal:
IUCrJ:S2052252519012399.
1. Introduction
Polyketides and nonribosomal peptides are two major classes
of natural products which give rise to nearly one third of the
current pharmacopoeia (Newman & Cragg, 2012). They
exhibit high structural diversity and are proven to be excellent
therapeutics, but there is an increasing interest in diversifying
current natural product libraries to produce analogues with
improved or novel biological activity (Cummings et al., 2014).
Natural products classed as polyketides, nonribosomal
peptides and hybrids of both are often biosynthesized by giant,
complex enzymes known as polyketide synthases (PKS) and
nonribosomal peptide synthetases (NRPS). Both systems
consist of a range of domains which incorporate a number of
starter and extender units to build a linear structure. In the
case of polyketides, the linear enzyme products can then be
further tailored by various enzymes, including cyclases,
oxidases, reductases and methylases, to yield a diverse array of
bioactive compounds (Olano et al., 2010).
Indanomycin (1) is an antibiotic from the pyrroloketo-
indane family which is known to act as an effective ionophoric
agent against Gram-positive bacteria (Dutton et al., 1995).
Indanomycin is synthesized in Streptomyces antibioticus
NRRL 8167 by a hybrid nonribosomal peptide synthetase/
polyketide synthase (NRPS/PKS; Li et al., 2009). The NRPS
portion of the pathway is proposed to generate a pyrrole
moiety from l-proline, which is then extended by the
sequential addition of malonyl-CoA, methylmalonyl-CoA and
ethylmalonyl-CoA building blocks by ten predicted PKS
modules to yield the linear nonribosomal peptide–polyketide
hybrid natural product 2 (Fig. 1). At least two cyclization
reactions are then needed to generate the tetrahydropyran
and tetrahydroindane rings of indanomycin (1; Fig. 1). The
former could be installed while the polyketide is still tethered
to the PKS by the cyclase domain, Cyc11, in the terminal, 11th
PKS module. Indane-ring formation has been postulated to be
catalysed by a separate indane cyclase, IdmH (Li et al., 2009;
Rommel et al., 2011), using a Diels–Alder [4+2] intramolecular
cyclization (Fig. 1). The feasibility of indane-ring formation in
indanomycin proceeding via a Diels–Alder reaction was first
shown in its complete chemical synthesis (Edwards et al.,
1984), but to date it has not been possible to characterize the
activity of IdmH in molecular detail.
The proposed biosynthetic cycloaddition would require the
appropriate diene and dienophile within the intermediate. The
indanomycin PKS harbours catalytic domains which would
produce the suitable diene intermediate for the cycloaddition
to be feasible. However, the required dienophile would not be
generated by straightforward use of the catalytic domains
present in the indanomycin PKS/NRPS, since the second PKS
module is predicted to install a hydroxyl group at C19 (Fig. 1,
compound 2; Rommel et al., 2011). To form the appropriate
dienophile, dehydration of the alcohol at C19 is therefore
needed, either while the linear polyketide is tethered to the
synthase or after it has been released. One suggested possi-
bility is that a dehydratase (DH) domain, for example DH3,
from a neighbouring module might catalyse the required
dehydration in a manner similar to that used in epothilone
biosynthesis (Tang et al., 2004; Li et al., 2009).
Irrespective of the activity required to dehydrate C19,
IdmH has been proposed to catalyse the Diels–Alder reaction
which would lead to the final indane-ring formation in inda-
nomycin. In support of this idea, an idmH deletion mutant of
S. antibioticus exhibited both a significant reduction in inda-
nomycin yield and the production of a previously unobserved
linear tetraene alternative product (Rommel et al., 2011).
Notably, indanomycin-production levels were restored when
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Figure 1
The proposed mechanism for indanomycin maturation through the formation of tetrahydropyran (green) and indane (blue) rings. After ‘starter’ pyrrole
biosynthesis, the polyketide is built through the actions of the five Idm ORFs IdmL–P, and the final polyketide chain is left attached to IdmP. Cyc11 is
thought to mediate the formation of the tetrahydropyran ring through a direct nucleophilic replacement to generate 3 (Li et al., 2009). This reaction
could then be followed by hydrolysis to release 4 from the IdmP subunit. Finally, indane-ring formation is thought to be mediated by a putative cyclase,
IdmH (Li et al., 2009). For [4+2] cycloaddition to occur, C19 of 2 (denoted with an asterisk) needs to be dehydrated to produce a double bond to act as
the dienophile (Rommel et al., 2011). Since the second PKS module does not contain a dehydratase domain, a hypothetical dehydration step was
included between intermediates 3 and 4. Adapted from Li et al. (2009).
the idmH gene was introduced to S. antibioticus in trans
(Rommel et al., 2011). IdmH is thus thought to be the key
cyclase responsible for the formation of the indane ring and
hence mature indanomycin. IdmH is a protein consisting of
145 amino acids (Supplementary Fig. S1) exhibiting sequence
similarity to a number of natural product-modifying enzymes.
These include the epoxide hydroxylase MonBI from
S. cinnamonensis (50% identity over 14% of the sequence;
Minami et al., 2014) and the polyketide cyclase SnoaL from
S. nogalater (27% identity over 91% of the sequence; Sultana
et al., 2004) (Supplementary Fig. S2). Both homologues exhibit
an + barrel fold and are involved in ring closure and
aromatic ring hydroxylations in the monensin and nogala-
mycin biosynthetic pathways, respectively. Beyond polyketide-
modifying enzymes, other + barrel proteins include 5-3-
ketosteroid isomerase and scylatone dehydratase (Ha et al.,
2001; Lundqvist et al., 1994), showing that nature has made
broad use of this fold in many biosynthetic pathways. Given
the diversity of reactions catalysed by enzymes displaying this
fold, it is challenging to predict the function of IdmH based on
sequence similarity alone.
As a step towards elucidating the underlying enzymatic
mechanism of indanomycin maturation, we set out to deter-
mine the three-dimensional structure of IdmH. Here, we
present crystal structures of IdmH and a deletion variant,
IdmH-99–107, at 2.7 and 2 A˚ resolution, respectively.
Structural analysis shows that IdmH has a similar fold to that
of the putative hydroxylases SnoAL2 and AcIR (Beinker et
al., 2006) and the polyketide cyclases SnoaL (Sultana et al.,
2004) and AknH (Kallio et al., 2006). Apparent differences in
the putative active site, however, suggest that this enzyme
catalyses a distinct reaction from that of its closest structural
homologues. We therefore utilized NMR spectroscopy and
in silico modelling [including quantum mechanical/molecular
mechanical (QM/MM) reaction simulations] to probe product
binding and the likely reaction catalysed by IdmH, with our
analyses supporting the notion that this enzyme is indeed a
Diels–Alderase.
2. Materials and methods
2.1. Plasmid construction
The gene sequence encoding the full-length idmH gene
(ACN69984.1) was amplified by PCR using the genomic DNA
from S. antibioticus (strain NRRL 8167) as a template, and the
forward and reverse primers 50-ctg gtg ccg cgc ggc agc cat ATG
GCT CAT CAG CCT TCG-30 and 50-tcc acc agt cat gct agc caT
CAC AGG GAC GCC TTC AC-30, respectively. The amplified
sequence contained overhang sequences (in lower case letters)
which facilitated ligation to an NdeI-linearized pET-28(a)+
vector using the NEBuilder HiFi DNA-assembly kit (NEB).
The generated plasmid also encoded an N-terminal hexa-
histidine tag on the protein and a thrombin cleavage site. The
gene insert was confirmed by sequencing with T7 and T7term
universal primers before transformation into Escherichia coli
strain BL21(DE3) cells for overexpression. Site-directed
mutagenesis to generate the deletion variant IdmH-99–107
was performed using wild-type pET-28_IdmH as a template
and the forward and reverse primers 50-CGC GAC CGC GAG
GGG TGG-30 and 50-GGA GTG CGT TCC CCG TGC-30,
respectively. The site-directed mutagenesis PCR product was
treated with KLD Enzyme Mix (NEB) before transformation
into E. coli strain 5- competent cells.
2.2. Expression and purification of IdmH
Recombinant IdmH was expressed in E. coli strain
BL21(DE3) cells harbouring the pET-28_IdmH plasmid. The
cells were grown in 2TY medium containing 50 mg ml1
kanamycin at 37C to an OD600 of 0.4 before lowering the
temperature to 15C. Expression was then induced with
0.4 mM isopropyl -d-1-thiogalactopyranoside (IPTG) at an
OD600 of 1.0 and the cells were allowed to grow overnight. The
cells were harvested by centrifugation at 6000g and subse-
quently resuspended in buffer A (50 mM Tris–HCl pH 7.4,
0.5 M NaCl) containing 20 mM imidazole, 0.1 mg ml1 lyso-
zyme, 0.05 mg ml1 DNase and 2 mM MgCl2. After disrupting
the cells with a high-pressure press (Constant Systems), the
cell debris was removed by centrifugation at 50 000g. The
supernatant was then loaded onto a 5 ml HisTrap HP column
(GE Healthcare, USA) which had been pre-equilibrated with
buffer A. Following sample loading, the column was washed
with ten volumes of buffer A before the target protein was
eluted from the column with buffer A supplemented with
200 mM imidazole. The eluted recombinant protein was
desalted into buffer B (10 mM Tris–HCl pH 7.2, 50 mM NaCl)
using a PD-10 desalting column (GE Healthcare, USA) and
the hexahistidine tag was then removed by incubating the
sample with 1 U thrombin (GE Healthcare, USA) per milli-
gram of recombinant IdmH overnight at 4C. Thrombin was
removed by loading the protein mixture onto a 5 ml HiTrap Q
column (GE Healthcare, USA) equilibrated with buffer B.
The column was washed with five column volumes of buffer B
before a linear gradient of increasing NaCl concentration was
applied to elute the bound proteins. 2.5 ml fractions were
collected across the gradient, which were analysed by SDS–
PAGE. Fractions containing the protein were pooled,
concentrated and applied onto a size-exclusion chromato-
graphy column (HiLoad 26/600 Superdex 75 pg, GE Health-
care, USA) pre-equilibrated with buffer B. After a void
volume of 40 ml, 1 ml fractions were collected. These were
once more analysed using SDS–PAGE and the fractions
containing the most highly pure IdmH were combined to form
the final sample. This was concentrated to 20 mg ml1 (as
determined from the A280 with an extinction coefficient of
17 990 M1 cm1) using a centrifugal filter concentration
device (Vivaspin 20; 10 000 molecular-weight cutoff). Finally,
samples were flash-frozen in liquid nitrogen and stored at
80C until use. The IdmH-99–107 variant was expressed
and purified in exactly the same way.
Production of selenomethionine-labelled IdmH-99–107
was achieved by cultivation of the methionine-auxotrophic
E. coli strain B834 (DE3) cells in M9 minimal medium
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supplemented with BME vitamins (Sigma–Aldrich) and
50 mg ml1 l-(+)-selenomethionine (Anatrace). All expres-
sion and purification steps were performed as for the native
protein. Incorporation of selenomethionine was confirmed by
LC/MS analysis.
2.3. Protein crystallization, X-ray data collection and
structure determination
Initial crystallization conditions for full-length IdmH were
identified with The JCSG Core Suites I–IV (Qiagen) using
Formulatrix NT8 robotic mixing of protein at 20 mg ml1 with
crystallization solution at 1:1, 2:1 and 1:2 volumetric ratios in
separate drops. IdmH crystal hit conditions were subsequently
optimized with respect to pH and precipitant concentration
using hanging-drop vapour diffusion, giving the crystals used
for data collection in 0.2 M calcium acetate, 0.1 M MES pH
5.5, 18.6%(w/v) polyethylene glycol 8000. The crystals were
cryoprotected by soaking them in mother-liquor solution
containing 20%(v/v) glycerol for about 30 s before flash-
cooling them by plunging them into liquid nitrogen. X-ray
diffraction data for full-length IdmH were collected on
beamline I04 at Diamond Light Source.
The structure of IdmH could not be determined by mole-
cular replacement using these data and the structure was
therefore solved using selenomethionine-labelled IdmH-99–
107. Crystals were obtained in 3.6–4 M sodium formate, 10–
15%(v/v) glycerol using the same approach as described for
the wild-type enzyme. The crystals were
flash-cooled in liquid nitrogen for data
collection, this time in the absence of
cryoprotectant. X-ray diffraction data
for selenomethionine-labelled IdmH-
99–107 were recorded on MASSIF-1
at the European Synchrotron Radiation
Facility (Bowler et al., 2015, 2016;
Svensson et al., 2015, 2018; Nurizzo et
al., 2016), while native IdmH-99–107
data were recorded on beamline I03 at
Diamond Light Source.
All diffraction data were indexed and
integrated using XDS (Kabsch, 2010)
before subsequent scaling in AIMLESS
and data processing using the CCP4i2
graphical user interface to CCP4
(Potterton et al., 2018). The structure of
IdmH-99–107 was determined to 2 A˚
resolution by single-wavelength anom-
alous dispersion (SAD) phasing using
the SHELX pipeline followed by
density modification using Parrot and
automated model building in Bucca-
neer. Iterative rounds of manual model
building and refinement were then
performed in Coot and REFMAC5,
respectively (Cowtan, 2006, 2010, 2012;
Murshudov et al., 2011; Sheldrick, 2010).
The structure of wild-type IdmH was solved by molecular
replacement using a single monomer of IdmH-99–107 as a
search model in Phaser (McCoy, 2007; McCoy et al., 2007). The
final model was once more generated following iterative
rounds of manual model building in Coot and refinement using
REFMAC5 imposing local noncrystallographic symmetry
(NCS) restraints throughout (Emsley & Cowtan, 2010;
Murshudov et al., 2011). The model was validated using
MolProbity (Chen et al., 2010). All data-collection and struc-
ture-refinement statistics are listed in Table 1.
2.4. NMR spectroscopy
950 MHz Bruker Ascend Aeon and 750 MHz Oxford NMR
spectrometers equipped with cryogenically cooled triple-
resonance probes were used for all NMR experiments. Spectra
were recorded at 25C in NMR buffer [20 mM Tris pH 7.3,
50 mM NaCl, 1 mM DTT, 0.02%(w/v) NaN3, 5%(v/v) D2O].
2D NMR experiments were carried out using Wilmad NMR
tubes (Precision, limit 600 MHz frequency), while Shigemi
NMR tubes were used for triple-resonance experiments.
2.4.1. Backbone nuclei resonance assignment. Triple-
labelled protein was obtained by growing E. coli BL21(DE3)
cells containing the wild-type IdmH expression plasmid in M9
medium prepared in D2O and supplemented with [
13C]-d-
glucose and 15NH4Cl (Cambridge Isotope Laboratories).
Labelled protein was purified as described for the wild type,
except that no thrombin-cleavage step was carried out. A set
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Table 1
Data-collection and refinement statistics.
Values in parentheses are for the highest resolution shell.
Selenomethionine-labelled
IdmH-99–107
Native
IdmH-99–107 Wild-type IdmH
Data collection
Wavelength (A˚) 0.966 0.976 0.9795
Space group F23 F23 P1211
a, b, c (A˚) 152.6, 152.6, 152.6 152.7, 152.7, 152.7 66.7, 103.5, 99.6
, ,  () 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 91.6, 90.0
Resolution (A˚) 76.3–2.2 (2.27–2.20) 76.3–2.0 (2.05–2.00) 51.8–2.7 (2.82–2.70)
Rmerge 0.118 (4.620) 0.046 (0.669) 0.086 (0.961)
Rmeas 0.120 (4.697) 0.053 (0.769) 0.097 (1.098)
Rp.i.m 0.022 (0.846) 0.026 (0.373) 0.046 (0.522)
hI/(I)i 20.8 (1.4) 12.7 (1.4) 11.4 (1.4)
CC1/2 0.999 (0.812) 0.999 (0.516) 0.998 (0.656)
Completeness (%) 100 (100) 99.9 (99.9) 99.6 (99.5)
Multiplicity 30.6 (30.6) 4.1 (4.1) 4.5 (4.3)
Refinement
Resolution (A˚) 88.1–2.2 88.2–2.0 103.5–2.7
No. of reflections (total/free) 14989/726 19980/974 37126/1832
Rwork/Rfree† 0.212/0.276 0.230/0.271 0.211/0.245
Total No. of atoms 3707 3704 19690
No. of ligands 0 0 0
No. of water molecules 13 27 9
Wilson B factor (A˚2) 48.3 48.4 60.7
R.m.s. deviations
Bond lengths (A˚) 0.016 0.007 0.012
Bond angles () 1.81 1.15 1.47
Ramachandran plot
Favoured (%) 98.8 98.8 98.46
Allowed (%) 1.2 1.2 1.47
Outliers (%) 0 0 0.07
Molecules in asymmetric unit 2 2 10
PDB code 6hnl 6hnm 6hnn
of 3D BEST-TROSY backbone resonance assignment spectra
[HNCA, HN(CO)CA, HNCO, HN(CA)CB and HN(CO)-
CACB] were recorded at 750 MHz, while a 3D BEST-TROSY
HN(CA)CO spectrum was recorded at 950 MHz, using pulse
sequences (Solyom et al., 2013) obtained from the Institut de
Biologie Structurale (IBS), Grenoble, France for [15N,13C,2H]-
labelled IdmH at a concentration of 0.8 mM. Non-uniform
sampling was used to speed up the acquisition time and obtain
high-resolution spectra.
The raw spectra were pre-processed with NMRPipe and
NMRDraw (Delaglio et al., 1995). Non-uniform sampled data
were reconstructed using the MddNMR suite (Jaravine &
Orekhov, 2006; Jaravine et al., 2008). Backbone nuclei reso-
nance assignment was performed using CCPNmr Analysis
(Vranken et al., 2005) and AutoAssign (Zimmerman et al.,
1997).
2.4.2. Chemical shift perturbation studies. 15N-labelled
protein was prepared by growing E. coli strain BL21(DE3)
containing the wild-type idmH expression plasmid in M9
minimal medium using 15NH4Cl as the sole nitrogen source.
1H–15N HSQC-TROSY spectra were collected at an IdmH
concentration of 0.2 mM with varying concentrations of
indanomycin (0–200 mM) at 25C at a field strength of
750 MHz. The raw data were pre-processed using TopSpin
(Bruker). The NMR spectra were analysed using CCPNmr
Analysis (Vranken et al., 2005). The minimal chemical shift
perturbation was calculated from 1H and 15N chemical shift
differences using 0.154 as a scaling factor for 15N shift changes
and calculating the closest chemical shift distance between
peaks in the spectra with and without indanomycin
(Williamson, 2013).
2.5. In silico modelling
Molecular docking of indanomycin (1) and an analogue
truncated at C8 was performed using AutoDock Vina 1.1.2
(Trott & Olson, 2010). AutoDockTools 1.5.4 was used to
merge the nonpolar hydrogens and define all formally single
bonds as rotatable bonds for docking. Subsequently, docking
was performed with AutoDock Vina using a grid of 25  20 
25 A˚ centred on the active-site cavity (in either chain A or
chain B of the crystal structure). Three top-scoring poses in
different orientations were selected by filtering out highly
similar poses and poses that did not place the indane ring
inside the cavity. Subsequently, the protein–product poses
(with the complete indanomycin) were prepared for mole-
cular-dynamics simulation with AmberTools17 (Case et al.,
2017) using the Enlighten protocols (see https://github.com/
marcvanderkamp/enlighten). For one of the poses, a different
hydrogen-bonding network was obtained by ‘flipping’ the
Asn117 side chain. Simulations were thus performed on four
different initial protein–product complexes. The PREP
protocol was used to prepare the protein–ligand system for
simulation, which involved (i) adding hydrogens [all residues
in their standard protonation states in line with prediction by
PROPKA 3.1 (Olsson et al., 2011; Søndergaard et al., 2011);
His44 singly protonated on H1 with all other His singly
protonated on H"2 as predicted by the AmberTools program
reduce], (ii) parameterization of indanomycin using AM1-
BCC partial charges and GAFF parameters assigned by
Antechamber (Wang et al., 2004, 2006) and (iii) solvation of the
active site with TIP3P water molecules (in a 20 A˚ sphere
centred on the N atom of indanomycin, in addition to crys-
tallographically determined water molecules). After a brief
structural optimization (using the STRUCT protocol, which
involves simulated annealing and energy minimization), a
molecular-dynamics simulation of 200 or 300 ps was
performed for each pose (using the DYNAM protocol at a
constant temperature of 298 K).
Snapshots from molecular-dynamics simulations between
100 and 300 ps were used to start approximate QM/MM
umbrella sampling simulations of the reverse Diels–Alder
reaction (at least 10 ps apart) using the same protocol as used
previously (Byrne et al., 2016) using DFTB2 (Elstner et al.,
1998) for indanomycin (QM region) and the Amber force field
ff14SB (Maier et al., 2015) for the enzyme environment. In
short, the reaction coordinate used to follow the Diels–Alder
reaction was the distance between the centre of mass of the
dienophile carbons (C19 and C20) and the centre of mass of
the diene carbons to which they bond (C15 and C12). By using
this reaction-coordinate definition, no bias is applied as to
which carbon–carbon bond is formed or broken first (or
indeed whether or not the bonds are formed/broken
synchronously). Umbrella sampling was performed from
reaction coordinate value 1.2 to value 3.8 A˚ (in steps of 0.1 A˚,
with additional windows at 2.15, 2.25 and 2.35 A˚). The same
conditions were used as in the DYNAM protocol, apart from
using a 1 fs timestep (instead of 2 fs). Snapshots were saved
every 0.5 ps. A restraint of 100 kcal mol1 A˚1 and 2 ps of
simulation was used for each umbrella sampling window.
Reaction-coordinate values were recorded every 1 fs and used
for input to the Weighted-Histogram Analysis Method
(WHAM; Grossfield, 2013), resulting in the potential of mean
force (free energy) along the reaction coordinate (bin width of
0.05 A˚). For each docking pose, 11 QM/MM reaction simula-
tions were performed, each starting from a different snapshot.
The QM/MM protocols are designed to limit computational
resources and are thus approximate. Our aim is not to analyse
the reaction in detail, but to distinguish between different
possible reactive binding poses. For example, the use of a
single, combined reaction coordinate (obtaining a 1D-PMF) is
less accurate than a 2D-PMF with sampling along two reaction
coordinates representing the carbon–carbon bonds formed
[see, for example, S´widerek & Moliner (2016), where this is
discussed in detail]. With the combined reaction coordinate
used here, reasonable sampling is obtained along the
minimum free-energy region indicated in a 2D-PMF (see
Supplementary Fig. S3). Although longer sampling (for
example 20 ps per window after a 2 ps equilibration) affects
the free-energy barriers for simulations, we have tested that
this does not significantly change the differences in the barrier
between different poses (similar to as reported by Hirvonen
et al., 2019). To obtain representative snapshots for the
approximate transition state, the centroid of the highest
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populated cluster was used, as obtained with hierarchical
agglomerative clustering on the r.m.s.d. of the indanomycin
atoms after alignment on the protein backbone on the
structures sampled in the windows with reaction-coordinate
restraints at 2.2 and 2.3 A˚.
3. Results
3.1. Structural determination of IdmH-D99–107 and native
IdmH
The N-terminally hexahistidine-tagged wild-type IdmH was
successfully expressed in E. coli strain BL21(DE3) cells and
purified to homogeneity, and the hexahistidine tag was
removed by thrombin cleavage. Size-exclusion chromato-
graphy and LC/MS analysis (Supplementary Fig. S4)
suggested a dimeric oligomeric state for this protein. Initial
attempts at crystallization yielded small needle-like crystals,
but optimization of these initial conditions produced larger
rod-shaped crystals. X-ray diffraction data were collected to
2.7 A˚ resolution, but attempts to determine the structure by
molecular replacement were unsuccessful, presumably owing
to the lack of a suitable search model and the large number of
molecules in the asymmetric unit as estimated using MATT-
PROB (Kantardjieff & Rupp, 2003).
To improve crystallization, a number of variants were
produced to reduce the surface entropy (Goldschmidt et al.,
2007) or to truncate predicted surface loops (Roy et al., 2010;
Supplementary Fig. S1 and Table S1). One variant, containing
a deletion of residues 99–107, resulted in large, easily repro-
ducible crystals in the cubic space group F23 [Supplementary
Fig. S5(b)] from new crystallization conditions. This protein
was also produced labelled with selenomethionine and crys-
tallized under identical conditions, allowing the crystal struc-
ture of IdmH-99–107 to be determined to 2 A˚ resolution
using selenium SAD phasing. The asymmetric unit comprises
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Figure 2
The structure of IdmH. (a, c) Ribbon diagrams showing the IdmH dimer architecture. Individual monomers are coloured green and blue, respectively.
The overall shape of the monomer can be described as a distorted /-barrel with the dimerization interface located between the -sheets. Each
monomer comprises four -helices (1–4) and five -strands (1–5). (b, d) Surface representation of the IdmH dimer. The surface is coloured using
APBS (Jurrus et al., 2018) according to the approximate electrostatic potential from 5 kT e1 (red) to 5 kT e1 (blue).
one copy of the IdmH-99–107 dimer with the entire poly-
peptide chain successfully modelled into density, except for
the N- and C-terminal regions. Both the selenomethionine-
labelled protein structure and the isomorphous native
structure of IdmH-99–107 were modelled independently
(Table 1), giving almost identical structures that superpose
with an r.m.s.d. of 0.12 A˚ over 257 amino acids. The remainder
of the structural description will focus on the unlabelled native
protein as this should best represent the natural form of the
enzyme. With this structure in hand, the crystal structure of
wild-type IdmH was determined by molecular replacement
using a single subunit of IdmH-99–107 as a search model
(Fig. 2). Electron-density maps were well defined for all ten
protomers in the asymmetric unit, allowing all chains to be
modelled, with the exception of some residues at the extreme
N- and C-termini (residues in the ranges 1–6 and 143–148).
The final model was refined at 2.7 A˚ resolution with an Rwork
of 0.21 and an Rfree of 0.24. Both models were checked with
MolProbity, revealing a high-quality model (MolProbity
scores of 1.00 and 0.91 for wild-type IdmH and IdmH-99–
107, respectively) with no Ramachandran outliers.
3.2. Analysis of the IdmH structure
3.2.1. The overall fold. The ten molecules in the asymmetric
unit for the wild-type protein form five almost identical
dimers. The following discussion of the IdmH structure will
therefore focus on the dimer formed by chains A and B unless
otherwise stated, as this represents the most well ordered
dimer based on an analysis of the overall B factors of the
chains. The structure of IdmH reveals a homodimer, with
individual protomers consisting of a core + barrel. Each
subunit is composed of a five-stranded mixed -sheet with four
strands (2–5) continuous in sequence and an additional
-strand (1), considerably shorter in length, provided later in
the polypeptide chain (Fig. 2). The -sheet of each subunit is
curved and forms the central part of a distorted + barrel.
The barrel is completed by three -helices (1–3) on the
periphery of the dimer and a fourth short helix (4)
completing the fold. The dimer assembly is driven by hydro-
phobic interactions between the -sheets from the two sub-
units, generating the dimer shown in Fig. 2.
At the centre of each protomer, a large hydrophobic pocket
is found which is proposed to form the IdmH active site (see
below). Two loops (residues 38–46 and 99–108) are located
near to the entrance of this hydrophobic pocket and limit the
access to the proposed active site from the bulk solvent.
Interestingly, the loop, which comprises residues 99–108 and is
partially truncated in the IdmH-99–107 variant, appears to
occupy two distinct conformations within each of the five
dimers in the asymmetric unit. Indeed, in each dimer each
protomer has this loop occupying either a more open or a
more closed conformation above the hydrophobic cavity.
Whilst we cannot rule this out as an artefact of the crystal-
lization, this suggests that this loop is likely to be highly
dynamic in solution and may also hint at a potential change in
conformation between the two protomers, suggesting the
potential for allostery in this enzyme (Supplementary Fig. S6).
Furthermore, studies of a number of Diels–Alderases have
shown that a loop covering the active site becomes more
ordered upon substrate binding and this loop could also play
such a role here (Byrne et al., 2016; Zheng et al., 2016).
3.2.2. The proposed active site. A deep hydrophobic pocket
penetrating towards the core of the barrel can be observed in
each IdmH protomer. It is likely that this constitutes the active
site of the enzyme (Fig. 3 and Supplementary Fig. S7). Each
pocket is lined by the side chains of residues Tyr16, Phe19,
Leu39, Trp59, Val62, Trp63, Met115, His129, Ser133 and
Asn135. We propose that the preponderance of hydrophobic
residues might act to steer the hydrophobic substrate (4 in
Fig. 1) into an appropriate conformation for facile ring cycli-
zation by acting as a natural product template, as observed by
others in structurally related cyclases (Barajas et al., 2017; Li et
al., 2010; Liu et al., 2015; Carey & Sundberg, 2007).
3.2.3. Sequence and structural homologues of IdmH.
BLASTp (Supplementary Fig. S2) and DALI searches against
the PDB revealed that the closest sequence and structural
homologue to IdmH is the putative polyketide cyclase from
Chromobacterium violaceum (PDB entry 4lgq; 30% sequence
identity; Joint Center for Structural Genomics, unpublished
work). Many of the closest structural and sequence matches,
however, stem from structural genomics efforts and thus lack
accompanying biochemical data and publications supporting
their functional annotation. The putative hydrolases AcIR
(PDB entry 2gey) and SnoaL2 (PDB entry 2gex) from
S. galilaeus and S. nogalater, respectively (Beinker et al., 2006)
as well as the polyketide cyclase SnoaL (PDB entry 1sjw;
Sultana et al., 2004) did appear as close structural matches to
the structure of IdmH even though they share at best 28%
sequence identity. We therefore focused our structural
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Figure 3
Detailed view of the putative IdmH active site, highlighting key residues.
The abundance of aromatic/hydrophobic residues in the active site might
play a role in the catalysis of indane-ring formation by guiding the mainly
hydrophobic substrate into an appropriate conformation for catalysis.
The residues are coloured according to the normalized consensus
hydrophobicity scale, where the most hydrophobic residues are red and
the most hydrophilic residues are white (Eisenberg et al., 1984).
comparisons against these
biochemically characterized
enzymes.
We superimposed the structure
of IdmH on its sequence homo-
logues using PyMOL (Schro¨-
dinger) and found that the
polyketide cyclase SnoaL from
the nogalamycin biosynthetic
pathway (PDB entry 1sjw;
Sultana et al., 2004) exhibited the
highest structural similarity to
IdmH as measured by the root-
mean-square deviation of the fit
(r.m.s.d. = 1.56 A˚ over 549
atoms) [Fig. 4(a)]. Crystal-
lographic analysis and gel-filtra-
tion chromatography experiments
both suggest that SnoaL forms a
tetramer in solution (Sultana et
al., 2004), in contrast to IdmH
which is homodimeric. SnoaL catalyses an intramolecular
aldol condensation using the conserved residue Asp121 as an
acid/base catalyst during the reaction. Other essential residues
for the activity of SnoaL include Asn33, Gln105 and two
histidines, His107 and His119. In contrast, the active site of
IdmH does not contain residues that can perform acid/base
chemistry at equivalent positions to the catalytic Asp121 and
His107 of SnoaL, but rather contains Thr131 and Asn117
instead [Fig. 4(b)]. Of note, Thr131 is implicated as important
in the suggested catalytic mechanism of IdmH discussed later.
Both active sites include many aromatic residues, and some of
them are conserved between the two proteins (for example
Phe19 in IdmH and Phe15 in SnoaL and His129 in IdmH and
His119 in SnoaL). There are also two tryptophan residues
(Trp63 in IdmH and Trp54 in SnoaL) that appear to be
conserved between these proteins; however, they appear to be
in entirely different orientations. These different orientations
could reflect genuine differences between these two structures
or they may arise from the fact that the SnoaL structure
contains a bound substrate. Furthermore, there are additional
tryptophan (Trp59) and tyrosine (Tyr16) residues in IdmH
which seem to be unique to this protein (SnoaL contains Tyr31
and Met11 at these locations) [Fig. 4(b)]. Taken together,
these data suggest that IdmH is unlikely to catalyze an aldol
condensation as found for SnoaL and is likely to interact with
its substrate in a different manner.
3.3. Investigating IdmH enzymatic activity by nuclear
magnetic resonance spectroscopy
We had no access to the potential IdmH substrate 4, so we
chose to investigate the binding of the product, indanomycin
(1), to the enzyme by 2D nuclear magnetic resonance (NMR)
spectroscopy. Although this did not allow us to directly test
the hypothesis that IdmH catalyses indane-ring formation, we
postulated that the enzyme would bind the product of the
reaction, providing evidence to support its role in indano-
mycin biosynthesis.
IdmH was labelled with 13C, 15N and 2H and, following the
collection and processing of a number of triple-resonance
spectra (Yamazaki et al., 1994; Supplementary Table S2), the
NMR resonances of backbone nuclei were assigned for 88% of
residues. To investigate indanomycin binding, [15N]-IdmH was
mixed with a stoichiometric amount of ligand (indanomycin)
and a 1H–15N HSQC-TROSY spectrum was acquired (Fig. 5).
Significant chemical shift perturbations (CSPs) for a number
of backbone amides compared with the native protein were
seen on addition of indanomycin, suggesting a binding event.
To investigate the binding further and to localize the
indanomycin-binding site, titration spectra with substoichio-
metric ligand:protein ratios were recorded. Significant shifts in
both the 1H and 15N spectra were observed for a number of the
assigned residues (see Supplementary Fig. S8 for examples of
specific residue chemical shift perturbations during the titra-
tion). Since shifts can be influenced by through-bond, through-
space and allosteric interactions, it is difficult to determine
whether the CSPs in IdmH are a result of direct binding or
conformational change. However, to localize the protein–
ligand interactions, the geometrical distance moved by each
peak was calculated for all assigned residues [Fig. 6(a)] and
chemical shifts larger than the standard deviation of all shifts
were mapped onto the IdmH diagram using yellow, orange
and red colours [Fig. 6(b)].
In the presence of indanomycin (the bound spectrum),
some resonances moved a substantial distance from their
resonance counterparts in the native protein (the free spec-
trum) making it impossible to match the two accurately. For
this reason, a ‘minimum chemical shift procedure’ was
employed (Farmer et al., 1996; Lu¨ttgen et al., 2002; Williamson,
2013). This method links each assigned free resonance to the
signal in the bound spectrum that has moved the least from the
position in the free spectrum. Therefore, each resonance is
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Figure 4
Comparison of IdmH (blue) with its sequence and structural homologue SnoaL (pink). (a) IdmH chain A
was aligned with SnoaL (PDB entry 1sjw) chain A using PyMOL. (b) Active-site residues in SnoaL (pink)
compared with their counterparts in IdmH (blue). While some residues appear to be conserved between
the two proteins (His129/His119, Trp63/Trp54 and Phe19/Phe19), the charged essential catalytic residues
His107 and Asp121 are unique to SnoaL. Another difference between the two active sites arises from
different choices and positioning of aromatic residues (Trp59/Tyr31 and Trp63/Trp54), while Tyr16 appears
to be completely unique to IdmH. Asterisks denote SnoaL catalytic residues (Sultana et al., 2004).
assigned a CSP, and while the true
change might be larger than that
assigned, it will never be smaller.
The results of chemical shift mapping
suggest that the most significant CSPs
are localized at the top of the hydro-
phobic cavity of IdmH (-helices 3–4)
and on the -sheet inside the pocket (-
strands 2–4) [Figs. 2 and 6(c)], consistent
with the predicted location of the IdmH
active site. A closer look at the active-
site residues [Fig. 6(d)] revealed that the
majority of the resonances exhibited a
moderate (Val62 and Met115) to large
(Trp59, Trp63 and Tyr16) shift. Two
resonances, Ser133 and Ile37, exhibited
a shift below the level of significance
(<0.72 p.p.m.) and three remaining
resonances, Thr131, Phe19 and His129,
do not have their backbone resonances
assigned. These results thus suggest that
indanomycin can bind to IdmH in the
proposed active site, and that binding,
and potentially catalysis, could induce
conformational changes which spread to
other areas of the enzyme, as high-
lighted by the more distal CSPs.
In a bid to obtain further details of
indanomycin binding to IdmH, we
performed both co-crystallization and
crystal-soaking experiments to try and determine a structure
of the product complex. Co-crystallization with the ligand
appeared to inhibit crystal formation, likely owing to the high
concentration of DMSO required to keep the ligand in solu-
tion, whilst crystal soaking did not result in significant new
electron density that could be confidently attributed to the
ligand. In the light of these results, we therefore elected to
explore computational methods as a means of further
analyzing the biochemical function of IdmH.
3.4. Docking the product and simulating the protein–product
complex
Having determined that indanomycin binds in the active
site of IdmH, we wanted to further explore the likely chemical
reaction catalysed by IdmH. Indanomycin was placed in the
wild-type IdmH active sites (chain A and B) using in silico
molecular docking. Three significantly different binding poses
were found (two in chain A and one in chain B). For the
binding pose in chain B, the conformer for Asn117 was
adjusted to provide a slight difference in the hydrogen-
bonding environment. This led to the following four options:
pose A, the indane ring bound in the chain A pocket but
without any specific hydrogen bonds being made; pose B, the
indane ring in the chain A pocket with a hydrogen bond
formed between Ser133 and the substrate carbonyl group
(C21 O); pose C, the indane ring in the chain B pocket with a
hydrogen bond formed between Ser133 and the substrate
carbonyl group (C21 O) but in a different orientation to
pose B (Fig. 8); pose D, the indane ring in the chain B pocket
with a hydrogen bond formed between Thr131 and the
substrate carbonyl group in which a new hydrogen-bond
network is formed in the protein between Asn117 and Tyr16.
Poses C and D are shown in Fig. 7 (after brief structural
optimization), with the main difference in binding pose arising
from the side-chain orientation of Asn117. Subsequently, brief
structural optimization and 100–300 ps molecular-dynamics
simulation was performed for each of the four poses.
3.5. QM/MM simulations of the reverse reaction
11 QM/MM reaction simulations (starting from indepen-
dent snapshots of the molecular-dynamics simulations) were
run for all four possible enzyme–substrate complexes using
the same approximate protocol as described in Byrne et al.
(2016). Representative (approximate) transition-state struc-
tures of these four complexes are shown in Fig. 8, together
with the free-energy profile obtained from the 11 simulations
together. Based on the energy barriers, reactions proceeding
from starting poses C and D are the most likely (Fig. 7). The
low barriers compared with poses A and B can be rationalized
based on the electron-withdrawing nature of the hydrogen
bond formed between Ser133 or Thr131 and the substrate
carbonyl at C21 (depending on the pose). Between the two,
pose D seems to be the most likely, based on a good fit with the
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Figure 5
1H–15N HSQC-TROSY spectra of [15N]-labelled IdmH alone (purple) and in the presence of a
stoichiometric amount of the ligand indanomycin (orange). Upon the addition of the ligand
indanomycin, significant changes in the chemical shifts of some peaks were observed.
cavity and some possible catalytic stabilization by the posi-
tioning of Trp59. The reaction barrier for option A is highest,
which could be expected owing to the lack of a (good)
hydrogen-bonding interaction in this pose; during the QM/
MM simulations a hydrogen bond to Trp59 can be formed (see
Fig. 8), but this interaction is more transient and thus does not
offer the same benefit as the hydrogen bonds formed in poses
C and D. MD and QM/MM simulation of option B lead to a
poorer fit with the active-site cavity, suggesting that this is an
unlikely starting point for catalysis by IdmH (Fig. 8).
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Figure 6
Chemical shift perturbations (CSPs) mapped onto IdmH following the addition of indanomycin. (a) Histogram showing the geometrical distance moved
by each peak assigned to a residue. Peaks are coloured from yellow to dark red as the value of the CSP increases. Chemical shifts which were smaller than
the standard deviation of all shifts (0.072 p.p.m.) are coloured pale cream. Surface (b) and ribbon (c) representations of IdmH with peak shifts mapped
using the same colour scheme as in (a). Residues which could not be assigned in the NMR spectrum are coloured white. (d) Active-site cavity of chain B
with the proposed catalytic residues coloured according to the same colour scheme as in (b) and (c).
The chemical shift mapping results (Fig. 6) further support
the observations from the approximate QM/MM simulations.
Pose D involves a hydrogen-bonding network between
Thr131, Asn117 and Tyr16 as well as catalytic stabilization
from Trp59. According to the NMR titration experiments, all
of these residues (except for Thr131, which could not be
assigned) are involved in protein–ligand interactions as
measured by significant CSPs (0.22 p.p.m. for Tyr16,
0.12 p.p.m. for Asn117 and 0.20 p.p.m. for Trp59). There are
also van der Waals interactions between the substrate and the
other residues with significant CSPs. It is further worth noting
that Ser133, which is involved in a hydrogen bond to the
substrate in pose C, displayed a CSP (0.012 p.p.m.) below the
level of significance (0.07 p.p.m.), making pose C less likely
than pose D. The reaction simulations indicate that an
asynchronous concerted mechanism is followed, with the
formation of the C15–C19 bond occurring first (and repre-
senting the reaction barrier; see Fig. 8); this is similar to the
situation in the intramolecular Diels–Alder reaction in
AbyU and indeed the uncatalysed reaction (Byrne et al.,
2016).
In summary, chemical shift perturbation mapping, in silico
docking and approximate QM/MM simulations reveal the
structure of the likely reactive IdmH–substrate complex and
show that the active-site shape, along with a critical hydrogen
bond, is likely to promote the correct conformation of the
substrate 4 (bringing together the diene and dienophile) and
provides an appropriate environment for the indane-ring
cyclization reaction to occur.
4. Discussion
The Diels–Alder reaction is of major synthetic value in
organic chemistry for the preparation of substituted six-
membered rings with the creation of up to
four new stereocenters (Stocking &
Williams, 2003). The potential use of
proteins to catalyse Diels–Alder reactions
stereoselectively under mild conditions
therefore remains of high interest. Until
recently, no natural enzymes that specifically
catalyse Diels–Alder reactions (i.e. Diels–
Alderases) were known (Jamieson et al.,
2019), and some progress was made with
obtaining catalytic antibodies and de novo
designed enzymes that catalyse a bimole-
cular Diels–Alder reaction (Gouverneur et
al., 1993; Siegel et al., 2010). During the late
1990s and early 2000s, three putative Diels–
Alderases involved in natural product
synthesis were reported: macrophomate
synthase (Watanabe et al., 2000), lovastatin
nonaketide synthase (LovB; Auclair et al.,
2000) and solanapyrone synthase (Sol5;
Katayama et al., 1998; Kasahara et al., 2010).
LovB and Sol5 have activities other than
catalysing a Diels–Alder reaction, which
makes proving any catalysis of the cyclo-
addition reaction difficult. The bimolecular
reaction catalysed by macrophomate
synthase is now thought to follow a stepwise
mechanism: Michael addition followed by
an aldol reaction (Guimara˜es et al., 2005). In
the 2010s, the first enzyme specifically cata-
lysing only a Diels–Alder reaction was
reported: SpnF, which is involved in the
biosynthesis of spinosyn A (Kim et al.,
2011). Subsequently, numerous standalone
Diels–Alderases have been identified,
especially from bacterial biosynthesis path-
ways, including the cofactor-free PyrI4
(Zheng et al., 2016) from the pyrroindo-
mycin biosynthetic pathway and its homo-
logues AbyU (Byrne et al., 2016) and VstJ
research papers
IUCrJ (2019). 6 Ieva Drulyte et al.  IdmH 11 of 14
Figure 7
Stereoview of the position and interactions of indanomycin docked in the wild-type IdmH
chain B active site after brief structural optimization. Top: pose C, indanomycin C21 O
hydrogen-bonds to Ser133. Bottom: pose D, indanomycin C21 O hydrogen-bonds to Thr131.
The Tyr16, Asn117 and Thr131 side-chain positions from the original crystal structure are
shown transparently in light grey.
(Hashimoto et al., 2015) from other spirotetronate-containing
natural products.
Here, we propose that IdmH from the biosynthesis of
indanomycin is another natural standalone Diels–Alderase.
Similar to the structurally characterized natural Diels–
Alderases AbyU (Byrne et al., 2016) and PyrI4 (Zheng et al.,
2016), the enzyme acts in the (final) tailoring steps of natural
product biosynthesis, does not require a cofactor and the
reaction catalysed is intermolecular. The IdmH structure is a
homodimeric ‘barrel’ that contains a ‘capping loop’. With the
capping loop closed, a cavity is formed that fits the substrate in
a conformation in which the diene and dienophile moieties are
positioned in line with a Diels–Alder reaction. Interestingly,
the structure and sequence of IdmH are substantially different
from those of AbyU and PyrI4 (as well as their homologues
from other spirotetronate and spirotetramate biosynthesis
pathways; Supplementary Fig. S9). Instead of a -barrel,
IdmH is an + barrel. There is no significant sequence
similarity between IdmH on the one hand and AbyU and
PyrI4 on the other, nor is there an obvious mapping of the four
antiparallel -strands to the four antiparallel -strands of the
AbyU and PyrI4 -barrels. Despite the absence of a clear
evolutionary relationship between the IdmH + barrel and
the -barrels of AbyU and PyrI4, the overall shape is similar,
with the substrate cavity near the capping loop in each case
(Supplementary Fig. S9; Hashimoto & Kuzuyama, 2016). This
raises the question of whether the emergence of these intra-
molecular Diels–Alderases with similar structures provide an
research papers
12 of 14 Ieva Drulyte et al.  IdmH IUCrJ (2019). 6
Figure 8
The results of approximate QM/MM reaction simulations (DFTB2/ff14SB). (a)–(d) show representative (approximate) transition-state structures of the
four possible enzyme–product complexes (obtained by clustering) together with their energy profiles in (e). Only part of the indanomycin structure is
shown in these panels for clarity, but the remainder of the indanomycin molecule (including the tetrahydropyran ring, which may or may not be cyclized
before IdmH-catalysed formation of the indane ring), was present in all simulations.
example of convergent evolution. Further, it indicates that not
only a -barrel scaffold, but also a + barrel scaffold, could
be used for the design of engineered or de novo designed
Diels–Alderases, thereby potentially allowing a broader range
of substrates.
5. NMR data
The NMR assignment data for IdmH have been deposited in
the Biological Magnetic Resonance Data Bank (BioMagRes-
Bank) with accession number 27838.
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